Product Information
DULOXETINE HCL DR 30 MG CAP is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.1058 per EA under NDC 82009017110. Its NADAC has been published 49 times since Sep 17, 2025.
FDA first approved this application on Jan 6, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009017110
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DULOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208706FDA Approved
1/6/2017
TE Code
AB
On Market Since
7/1/2025
Pharmacological Classes
Price Statistics
The NADAC for DULOXETINE HCL DR 30 MG CAP has been published 49 times since Sep 17, 2025, and over the history we have for it it has risen 35.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1058 per EA |
|---|---|
| All-time high | $0.1058 (Aug 19, 2026) |
| All-time low | $0.0781 (Jan 21, 2026) |
| 52-week high | $0.1058 |
| 52-week low | $0.0781 |
| Median price | $0.0789 |
| Average price | $0.0868 |
| Largest weekly change | +12.2% (Apr 22, 2026) |
| Weeks tracked | 49 |
| Tracking since | Sep 17, 2025 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DULOXETINE HCL DR 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 30 MG CAP, manufactured by Quallent Pharmaceuticals Health LLC, is $0.1058 per EA (NDC 82009017110), effective Aug 19, 2026.
How has the price of DULOXETINE HCL DR 30 MG CAP changed over time?
Over the history we have for it, the NADAC for DULOXETINE HCL DR 30 MG CAP has risen 35.3%. It has been tracked across 49 weekly CMS publications since Sep 17, 2025.
What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 30 MG CAP?
Since Sep 17, 2025, the NADAC for DULOXETINE HCL DR 30 MG CAP has ranged from a low of $0.0781 (Jan 21, 2026) to a high of $0.1058 (Aug 19, 2026), with a median of $0.0789 per EA.
Are there cheaper alternatives to DULOXETINE HCL DR 30 MG CAP?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DULOXETINE HCL DR 30 MG CAP, is $0.0782 per EA — about 26% below DULOXETINE HCL DR 30 MG CAP.
Who manufactures DULOXETINE HCL DR 30 MG CAP?
DULOXETINE HCL DR 30 MG CAP (NDC 82009017110) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.